| Origin | Drug |
| first synthesized in 1938 by Sandoz chemist Albert Hofmann looking for a blood stimulant; its hallucinogenic effect prompted Western intelligence experiments in mass mind control | |
| naturally occurring substance produced by the fermentation of grains and fruits | |
| first synthesized by Ciba chemist Leandro Panizzon in 1944, now used to treat ADHD, ADD, hyperactivity, and narcolepsy* | |
| derived from PCP in 1962 by Parke-Davis scientist Calvin Stevens as a fast-acting general anesthetic; effective in treating depression in those with bipolar disorder* | |
| made from the Indian hemp plant, grown for use as a hallucinogen for more than 2,000 years* | |
| first isolated in 1830 by Jean-Pierre Robiquet to replace raw opium for medical purposes; used mainly as a cough remedy today* | |
| first synthesized in 1926 and later tested as a human and veterinary surgical anesthetic; only used for a few years because of side-effects: hallucinations, mania, delirium | |
| | Origin | Drug |
| developed in 1937 by IG Farben scientists Max Bockmühl and Gustav Ehrhart, it became widely used as a 'non-addictive' treatment for heroin addiction* | |
| first developed in Japan in 1919 as a stimulant; during WWII, both sides used it to keep troops awake; later it was prescribed as a diet aid and to fight depression | |
| first synthesized in 1912 by Merck chemist Anton Köllisch as a compound used for making the hemastatic drug, methylhydrastinine; later deemed possibly useful in psychotherapy | |
| first isolated in 1804 by Friedrich Sertürner as a 'non-addictive' substitute for opium in relieving severe pain* | |
| first isolated from coca leaves in 1859 by German chemist Albert Niemann; later promoted as a cure for depression and sexual impotence | |
| first manufactured in 1898 by the Bayer pharmaceutical company as a cough suppressant, a treatment for tuberculosis, and a 'non-addictive' remedy for morphine addiction* | |
| naturally occurring in the brain, it was first synthesized in 1960 by Dr. Henri Laborit as a surgical anesthetic; it failed; later marketed as a fat burner and muscle developer | |
|